title: Progress in novel cognitive enhancers for cognitive aging and Alzheimer's disease.
abstract: Increased knowledge of the biology of synaptic function has led to the development of novel cognitive-enhancing therapeutic strategies with the potential for increased efficacy and safety. This editorial highlights a diverse array of approaches currently being explored to target cognitive dysfunction due to aging and/or Alzheimer's disease.
authors.affiliation: Alzheimer's Drug Discovery Foundation, 57 West 57th Street, Suite 904, New York, NY 10019, USA.
authors.forename: Diana W
authors.initials: DW
authors.lastname: Shineman
authors.affiliation: Alzheimer's Drug Discovery Foundation, 57 West 57th Street, Suite 904, New York, NY 10019, USA.
authors.forename: Aaron J
authors.initials: AJ
authors.lastname: Carman
authors.affiliation: Alzheimer's Drug Discovery Foundation, 57 West 57th Street, Suite 904, New York, NY 10019, USA.
authors.forename: Penny A
authors.initials: PA
authors.lastname: Dacks
authors.affiliation: Alzheimer's Drug Discovery Foundation, 57 West 57th Street, Suite 904, New York, NY 10019, USA.
authors.forename: Rachel F
authors.initials: RF
authors.lastname: Lane
authors.affiliation: Alzheimer's Drug Discovery Foundation, 57 West 57th Street, Suite 904, New York, NY 10019, USA.
authors.forename: Howard M
authors.initials: HM
authors.lastname: Fillit